Download PDF
J Knee Surg 2018; 31(09): 841-845
DOI: 10.1055/s-0037-1615822
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Have the Annual Trends of Total Knee Arthroplasty in Rheumatoid Arthritis Patients Changed?

Matthew A. Harb
1   Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, New York
,
Max Solow
2   Saint George's University School of Medicine, True Blue, Grenada, West Indies
,
Jared M. Newman
1   Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, New York
,
Nipun Sodhi
3   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Robert Pivec
1   Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, New York
,
Jaiben George
3   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Assem A. Sultan
3   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Anton Khlopas
3   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Neil V. Shah
1   Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, New York
,
Martin W. Roche
4   Department of Orthopedic Surgery, Holy Cross Orthopedic Institute, Fort Lauderdale, Florida
,
Michael A. Mont
3   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

09 October 2017

22 November 2017

Publication Date:
03 January 2018 (online)

    Permissions and Reprints

Abstract

As the use of disease modifying antirheumatic drugs have increased, it remains unclear whether or not this has affected the rates of total knee arthroplasty (TKA) in rheumatoid arthritis (RA) patients. Therefore, the purpose of this study was to evaluate the annual trends of RA patients who underwent TKA. Specifically, we evaluated: (1) the annual trends of TKAs due to RA in the United States population; and (2) the annual trends in the proportion of TKAs due to RA in the United States. The Nationwide Inpatient Sample was used to identify all patients who underwent TKA between 2002 and 2013 (n = 6,492,873). Then, we identified TKA patients who had a diagnosis of RA, defined by the International Classification of Diseases, Ninth Revision (ICD-9) code 714.0. The incidence of TKAs with a diagnosis of RA in the United States was calculated using the U.S. population as the denominator. Regression models were used to analyze the annual trends of RA in patients who underwent TKA. A total of 209,332 RA patients were identified who underwent TKA. The annual prevalence of RA in patients who underwent TKA slightly increased, from 33.2 per 1,000 TKAs in 2002 to 35 per 1,000 TKAs in 2013 (R 2 = 0.254, p = 0.095). The annual number of TKAs with a diagnosis of RA increased by 93.1% from 11,618 to 22,430. After normalizing for the U.S. population, the incidence of TKAs with RA increased from 5.4 to 9.2 TKAs per 1 million U.S. adults (incidence rate ratio [IRR] = 1.05; 95% confidence interval [CI], 1.05–1.05; p < 0.001). In 2002, 11,618 (3.31%) TKAs, and in 2013, 22,430 (3.50%) TKAs were due to RA. The prevalence of RA in those who underwent TKA remained the same from 2002 to 2013 (coefficient = 0.02; 95% CI, –0.01 to 0.05; p = 0.095). The results of this study demonstrated that the rates of TKA performed in RA patients have remained relatively stable. Furthermore, there may have been a decline in the rate of RA patients undergoing TKA, due to an increase in the U.S. population by approximately 28.8 million during the study period.

Keywords

total knee arthroplasty - rheumatoid arthritis - annual trends
 

  • References

  • 1 Detert J, Klaus P. Biologic monotherapy in the treatment of rheumatoid arthritis. Biologics 2015; 9: 35-43
    PubMedGoogle Scholar
  • 2 Dusad A, Pedro S, Mikuls TR. , et al. Impact of total knee arthroplasty as assessed using patient-reported pain and health-related quality of life indices: rheumatoid arthritis versus osteoarthritis. Arthritis Rheumatol 2015; 67 (09) 2503-2511
    PubMedGoogle Scholar
  • 3 Goodman SM, Johnson B, Zhang M. , et al. Patients with rheumatoid arthritis have similar excellent outcomes after total knee replacement compared with patients with osteoarthritis. J Rheumatol 2016; 43 (01) 46-53
    PubMedGoogle Scholar
  • 4 Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998; 41 (06) 1072-1082
    CrossrefPubMedGoogle Scholar
  • 5 Hotfiel T, Carl H-D, Eibenberger T. , et al. Cementless femoral components in bicondylar hybrid knee arthroplasty in patients with rheumatoid arthritis: a 10-year survivorship analysis. J Orthop Surg (Hong Kong) 2017; 25 (02) 2309499017716252
    PubMedGoogle Scholar
  • 6 Schrama JC, Espehaug B, Hallan G. , et al. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken) 2010; 62 (04) 473-479
    PubMedGoogle Scholar
  • 7 Picchianti-Diamanti A, Germano V, Ferlito C, Migliore A, D'Amelio R, Laganà B. Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept. Qual Life Res 2010; 19 (06) 821-826
    CrossrefPubMedGoogle Scholar
  • 8 Schiff MH, Yu EB, Weinblatt ME. , et al. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies. Drugs Aging 2006; 23 (02) 167-178
    CrossrefPubMedGoogle Scholar
  • 9 Mathias SD, Colwell HH, Miller DP, Moreland LW, Buatti M, Wanke L. Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo. Clin Ther 2000; 22 (01) 128-139
    CrossrefPubMedGoogle Scholar
  • 10 Nam JL, Ramiro S, Gaujoux-Viala C. , et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2014; 73 (03) 516-528
    CrossrefPubMedGoogle Scholar
  • 11 Donahue KE, Jonas DE, Hansen RA. , et al. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults (Comparative Effectiveness Reviews, No. 55). Rockville, MD: Agency for Healthcare Research and Quality; 2012
    Google Scholar
  • 12 Horton SC, Buch MH. Immunotherapy. In: Emery P. , ed. Atlas of Rheumatoid Arthritis. Tarporley:: Springer Healthcare Ltd.; 2015: 195-232
    CrossrefGoogle Scholar
  • 13 Saag KG, Teng GG, Patkar NM. , et al; American College of Rheumatology. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59 (06) 762-784
    CrossrefPubMedGoogle Scholar
  • 14 Nationwide Inpatient Sample HCUP. (NIS). Healthcare Cost and Utilization Project (HCUP). 2013. Agency for Healthcare Research and Quality, Rockville, MD. Available at: www.hcup-us.ahrq.gov/nisoverview.jsp.2015 . Accessed July 12, 2016
    PubMedGoogle Scholar
  • 15 Gaffo A, Saag KG, Curtis JR. Treatment of rheumatoid arthritis. Am J Health Syst Pharm 2006; 63 (24) 2451-2465
    CrossrefPubMedGoogle Scholar
  • 16 Sizova L. Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs. Br J Clin Pharmacol 2008; 66 (02) 173-178
    CrossrefPubMedGoogle Scholar
  • 17 Hekmat K, Jacobsson L, Nilsson J-Å. , et al. Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis--results from a well defined population in south Sweden. Arthritis Res Ther 2011; 13 (02) R67
    CrossrefPubMedGoogle Scholar
  • 18 George J, Newman JM, Ramanathan D, Klika AK, Higuera CA, Barsoum WK. Administrative databases can yield false conclusions-an example of obesity in total joint arthroplasty. J Arthroplasty 2017; 32 (9S): S86-S90
    CrossrefPubMedGoogle Scholar
  • 19 Vinet E, Kuriya B, Widdifield J, Bernatsky S. Rheumatoid arthritis disease severity indices in administrative databases: a systematic review. J Rheumatol 2011; 38 (11) 2318-2325
    PubMedGoogle Scholar
  • 20 Ng B, Aslam F, Petersen NJ, Yu H-J, Suarez-Almazor ME. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study. Arthritis Care Res (Hoboken) 2012; 64 (10) 1490-1496
    PubMedGoogle Scholar
  • 21 Bozic KJ, Bashyal RK, Anthony SG, Chiu V, Shulman B, Rubash HE. Is administratively coded comorbidity and complication data in total joint arthroplasty valid?. Clin Orthop Relat Res 2013; 471 (01) 201-205
    CrossrefPubMedGoogle Scholar
  • 22 Stundner O, Danninger T, Chiu Y-L. , et al. Rheumatoid arthritis vs osteoarthritis in patients receiving total knee arthroplasty: perioperative outcomes. J Arthroplasty 2014; 29 (02) 308-313
    CrossrefPubMedGoogle Scholar
  • 23 Yoshihara H, Yoneoka D, Margalit A, Zuckerman JD. Rheumatoid arthritis patients undergoing total hip and knee arthroplasty have better in-hospital outcomes compared with non-rheumatoid arthritis patients. Clin Exp Rheumatol 2016; 34 (02) 270-275
    PubMedGoogle Scholar
  • 24 Sulaiman W, Toib A, Chandrashekhar G, Arshad A. The trends of DMARDS prescribed in rheumatoid arthritis patients in Malaysia. Oman Med J 2009; 24 (04) 260-06
    PubMedGoogle Scholar
  • 25 Pope JE, Hong P, Koehler BE. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists. J Rheumatol 2002; 29 (02) 255-260
    PubMedGoogle Scholar
  • 26 Momohara S, Tanaka S, Nakamura H. , et al. Recent trends in orthopedic surgery performed in Japan for rheumatoid arthritis. Mod Rheumatol 2011; 21 (04) 337-342
    CrossrefPubMedGoogle Scholar
  • 27 Yasui T, Nishino J, Kadono Y. , et al. Impact of biologics on the prevalence of orthopedic surgery in the National Database of Rheumatic Diseases in Japan. Mod Rheumatol 2010; 20 (03) 233-237
    CrossrefPubMedGoogle Scholar
  • 28 Sokka T, Kautiainen H, Hannonen P. Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003: an indication of improved long-term outcomes of rheumatoid arthritis. Ann Rheum Dis 2007; 66 (03) 341-344
    CrossrefPubMedGoogle Scholar
  • 29 Chow JC, Breslauer L. The use of intraoperative sensors significantly increases the patient-reported rate of improvement in primary total knee arthroplasty. Orthopedics 2017; 40 (04) e648-e651
    CrossrefPubMedGoogle Scholar
  • 30 Peters CL, Shirley B, Erickson J. The effect of a new multimodal perioperative anesthetic regimen on postoperative pain, side effects, rehabilitation, and length of hospital stay after total joint arthroplasty. J Arthroplasty 2006; 21 (06) (Suppl. 02) 132-138
    CrossrefPubMedGoogle Scholar
  • 31 Maheshwari AV, Blum YC, Shekhar L, Ranawat AS, Ranawat CS. Multimodal pain management after total hip and knee arthroplasty at the Ranawat Orthopaedic Center. Clin Orthop Relat Res 2009; 467 (06) 1418-1423
    CrossrefPubMedGoogle Scholar
  • 32 Vadivelu N, Mitra S, Narayan D. Recent advances in postoperative pain management. Yale J Biol Med 2010; 83 (01) 11-25
    PubMedGoogle Scholar
  • 33 Shourt CA, Crowson CS, Gabriel SE, Matteson EL. Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality. J Rheumatol 2012; 39 (03) 481-485
    PubMedGoogle Scholar
  • 34 Ward MM. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis Rheum 2004; 50 (04) 1122-1131
    CrossrefPubMedGoogle Scholar
  • 35 Skyttä ET, Honkanen PB, Eskelinen A, Huhtala H, Remes V. Fewer and older patients with rheumatoid arthritis need total knee replacement. Scand J Rheumatol 2012; 41 (05) 345-349
    CrossrefPubMedGoogle Scholar
  • 36 Mckeown EJ. The ethical challenges in rheumatology. Curr Rev Musculoskelet Med 2015; 8 (02) 107-112
    CrossrefPubMedGoogle Scholar
  • 37 Almoallim H, Janoudi N, Attar SM. , et al. Determining early referral criteria for patients with suspected inflammatory arthritis presenting to primary care physicians: a cross-sectional study. Open Access Rheumatol 2017; 9: 81-90
    PubMedGoogle Scholar
  • 38 U.S. Food & Drug Administration. FDA Approved Drug Products. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm . Accessed September 15, 2017
    PubMedGoogle Scholar